← Eichor
Condition: Lung Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lung Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NA · 1 location(s) · Guo ShiWei · NCT06632886Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
Phase 2 · 2 location(s) · BeBetter Med Inc · NCT06706713KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Phase 1 · 2 location(s) · Christian Hinrichs · NCT05483491The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Phase 2 · 1 location(s) · Xiaorong Dong · NCT05745350JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC
Phase 2 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT06969027Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
NA · 2 location(s) · Xinqiao Hospital of Chongqing · NCT0575420368Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06756217Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Phase 1/Phase 2 · 11 location(s) · Chipscreen Biosciences, Ltd. · NCT05271292Integrating Telehealth to Advance Lung Cancer Screening
NA · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT06638554ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
Phase N/A · 1 location(s) · Fang Wu · NCT05198154Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced
Phase 2 · 7 location(s) · Korea Institute of Oriental Medicine · NCT06249854The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Phase N/A · 2 location(s) · Sun Yat-sen University · NCT06801977A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment
Phase N/A · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT05857800Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Montefiore Medical Center · NCT06865339A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
NA · 1 location(s) · Nantes University Hospital · NCT06481813Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Phase 3 · 1 location(s) · Akeso · NCT06928389A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mut
Phase 3 · 5 location(s) · Astellas Pharma Global Development, Inc. · NCT07566052Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
Phase N/A · 11 location(s) · Istituto Clinico Humanitas · NCT07401615Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
Phase N/A · 1 location(s) · University of Utah · NCT06934343Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Phase 1 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06128148ATATcH Alternating Treatment Plans for Advanced Cancer
Phase 2 · 11 location(s) · Rutgers, The State University of New Jersey · NCT05358548Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
Phase 2 · 1 location(s) · Asrar Alahmadi · NCT07423585A Study of a New PET Scanner in People With Cancer
Phase N/A · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07690917Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
NA · 1 location(s) · Scientific Institute San Raffaele · NCT06626178Establishment of a Tumor Bank for Blood Samples
Phase N/A · 6 location(s) · Medical University of Vienna · NCT01763125
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.